|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001924,
umls-concept:C0011860,
umls-concept:C0017564,
umls-concept:C0021760,
umls-concept:C0030191,
umls-concept:C0030705,
umls-concept:C0205265,
umls-concept:C0266929,
umls-concept:C0441889,
umls-concept:C1555582,
umls-concept:C1623117,
umls-concept:C1882340
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-25
|
|
pubmed:abstractText |
To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabetic patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1420-908X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
143-51
|
|
pubmed:meshHeading |
pubmed-meshheading:20845058-Adult,
pubmed-meshheading:20845058-Albumins,
pubmed-meshheading:20845058-Chronic Periodontitis,
pubmed-meshheading:20845058-Diabetes Mellitus, Type 2,
pubmed-meshheading:20845058-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20845058-Female,
pubmed-meshheading:20845058-Gingival Crevicular Fluid,
pubmed-meshheading:20845058-Humans,
pubmed-meshheading:20845058-Interleukin-6,
pubmed-meshheading:20845058-Male,
pubmed-meshheading:20845058-Middle Aged,
pubmed-meshheading:20845058-Plasminogen Activator Inhibitor 2,
pubmed-meshheading:20845058-Tissue Plasminogen Activator
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes.
|
|
pubmed:affiliation |
Department of Periodontology, School of Dentistry, Ege University, 35100 Bornova, ?zmir, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
